Kurser indlæses...

Prognose

Køb	0
Behold	1
Sælg	0

Nyheder Til nyhedsfeedet

Extendicare reports strong Q2 growth as acquisitions drive revenue and EBITDA

Extendicare posted Q2 revenue up 59.4% to C$611 million and adjusted EBITDA up 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, acquired Revera homes and Closing the Gap. CBI added C$145.7 million of revenue and C$18.5 million of adjusted EBITDA; management expects a methodical 18–24 month integration delivering C$7.4 million of annual cost synergies. The company refinanced debt, lowering its weighted-average interest rate to 4.4% and reducing pro forma leverage to about 2.5x, while advancing six long-term-care redevelopment projects and planning to add 832 beds across four openings in 2027. Home health volumes rose sharply but margins were modestly pressured by investment in technology and support functions; management expects longer-term volume growth of about 6–8% annually. » Mere på finance.yahoo.com
Extendicare beats revenue forecasts, misses earnings and stock falls

Extendicare reported second-quarter 2026 revenue of 611 million CAD (+59.4%), well above expectations, while earnings of $0.319 per share missed the analyst estimate of $0.34. Adjusted EBITDA rose to 68.3 million CAD and adjusted results improved, but transaction, integration and refinancing costs weighed on net income. Management says the CBI integration is still in its early stages and expects 18–24 months for full integration, along with further investments in long-term care and home health. The stock fell about 8.7% in after-hours trading to $31.22 as investors put more weight on the earnings miss and near-term margin risks than on revenue growth. » Mere på de.investing.com
Extendicare beats Q1 2026 earnings expectations by a wide margin and stock rises

Extendicare reported Q1 2026 EPS of 0.422 CAD, surpassing the analyst estimate of 0.2033 CAD by 107.6%. Revenue was 465.2 million CAD (+24.2% y/y), slightly below expectations, while adjusted EBITDA and AFFO rose markedly. Strong volume growth in the home-healthcare segment (32.7%) was driven by acquisitions and organic growth; the acquisition of CBI Home Health was completed. The stock climbed 10.84% after hours to 33.44 CAD; management continues to reaffirm ambitious profit and revenue guidance for 2026/2027. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2026 har EXTENDICARE INC. allerede udloddet 0,27 € i udbytte. Den seneste udlodning fandt sted i oktober.

Virksomhedstal

I det seneste kvartal havde EXTENDICARE INC. en omsætning på 376,83 mio. € og et nettoresultat på 19,03 mio. €

(EUR)	juni 2026	YoY
Omsætning	376,83 mio.	57,61 %
Bruttofortjeneste	376,83 mio.	57,61 %
Nettoresultat	19,03 mio.	4,43 %
EBITDA	38,66 mio.	14,23 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	1,68 mia. €
Antal aktier	95,05 mio.
Højeste/laveste i 52 uger	24,87 € - 10,04 €
Udbytteafkast	1,86 %
Udbytte TTM	0,32 €
Næste udbytte	0,028 €
Beta	1,08
P/E (PE Ratio)	21,07
PEG (PEG Ratio)	0,95
K/I (PB Ratio)	6,56
P/S (PS Ratio)	1,34

Virksomhedsprofil

Extendicare Inc. leverer gennem sine datterselskaber pleje og services til ældre i Canada. Selskabet tilbyder langtidspleje (LTC)-ydelser; plejeboliger med selvstændig bolig; og hjemmesygepleje, såsom plejeydelser, ergoterapi, fysioterapi og talterapi samt hjælp til daglige aktiviteter, samt kontrakt- og konsulentydelser til tredjeparter. Det driver et netværk på 119 LTC-hjem og pensionistfællesskaber samt hjemmesygepleje under mærkerne Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist og SGP Purchasing Partner Network. Extendicare Inc. blev grundlagt i 1968 og har hovedkontor i Markham, Canada.